Novo Nordisk's OpenAI Partnership & How AI is Revolutionizing Drug Development

Novo Nordisk teamed up with OpenAI, a partnership intended to shorten timelines and improve accuracy in drug development. In this episode, Kelsey Sung interviews Cliff Saran of Computer Weekly about Novo Nordisk's groundbreaking partnership with OpenAI. They explore how AI is transforming drug development, reducing timelines, and addressing challenges in healthcare innovation. This collaboration also hints at a future where AI might reduce the need for animal testing, a controversial but promising step forward in ethical research. Featuring: Cliff Saran, Computer Weekly Read more: Novo Nordisk partners with OpenAI to AI-power drug development